Â鶹´«Ã½

Skip to main content

Displaying 1 - 20 of 1990

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin)

The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
221 0114
Docket Number
9437
Case Status
Pending

FTC Releases Summary of Key Accomplishments

Date
Â鶹´«Ã½ Trade Commission Chair Lina M. Khan released a summary of the agency’s key accomplishments over the last four years that have improved Americans’ everyday lives and stopped illegal...

FTC Approves Final Order in Exxon-Pioneer Deal

Date
The Â鶹´«Ã½ Trade Commission today finalized a consent order that resolves antitrust concerns surrounding Exxon Mobil Corporation’s (Exxon) acquisition of oil producer Pioneer Natural Resources. The...

FTC Approves Final Order in Chevron-Hess Deal

Date
The Â鶹´«Ã½ Trade Commission today finalized a consent order that resolves antitrust concerns surrounding Chevron Corporation’s acquisition of oil producer Hess Corporation. The final consent order...